- The alkylating medication Mitomycin is recommended for treating adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC).
The most frequent side effects (≥20%) include fatigue, nausea, vomiting, dysuria, ureteric blockage, flank discomfort, urinary tract infection, hematuria, and renal failure.
Does the FDA approve Mitomycin?
On April 15, 2020, the Food and Drug Administration approved Mitomycin (JELMYTO, UroGen Pharma) for adult patients with low-grade upper tract urothelial cancer (LG-UTUC).
Is Mitomycin used in chemotherapy?
Mitomycin is a chemotherapy drug used to treat different cancers, including breast, bladder, stomach, pancreatic, anal, and lung cancers.
Why use Mitomycin?
Mitomycin C (MMC) is an antimetabolite used during the initial stages of a trabeculectomy to prevent excessive postoperative scarring and thus reduce the risk of failure.
What are the uses of Mitomycin?
Mitomycin 40 mg solution is used to treat symptoms of pancreatic and stomach cancer and is under clinical research for its potential to treat
What are the ingredients in the medicine with Mitomycin?
The medication’s active ingredient is Mitomycin, and the inactive ingredient is Mannitol.